These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12775623)

  • 21. Conflicts of Interest.
    Abramson J; Redberg R
    N Engl J Med; 2015 Aug; 373(8):778. PubMed ID: 26287862
    [No Abstract]   [Full Text] [Related]  

  • 22. Conflicts of Interest.
    Rosenbaum L
    N Engl J Med; 2015 Aug; 373(8):779-80. PubMed ID: 26287861
    [No Abstract]   [Full Text] [Related]  

  • 23. No more free lunches: it is time we all grew up.
    Wessely S
    BMJ; 2003 Aug; 327(7410):341. PubMed ID: 12907497
    [No Abstract]   [Full Text] [Related]  

  • 24. Dangerous liaisons: doctors-in-training and the pharmaceutical industry.
    Pokorny AM; Gittins CB
    Intern Med J; 2015 Oct; 45(10):1085-8. PubMed ID: 26429220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dos and don'ts of collaborating with industry.
    Moynihan R
    BMJ; 2012 May; 344():e3247. PubMed ID: 22569871
    [No Abstract]   [Full Text] [Related]  

  • 26. No more free lunches: it is time to own up.
    Fitzpatrick C
    BMJ; 2003 Aug; 327(7410):342. PubMed ID: 12907499
    [No Abstract]   [Full Text] [Related]  

  • 27. Money for drugs: should physicians be paid for pharmaceutical development and clinical investigations?
    Van Way C; Bohigian G; Gale A; Powell M; Hagan JC
    Mo Med; 2011; 108(5):320-9. PubMed ID: 22073488
    [No Abstract]   [Full Text] [Related]  

  • 28. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Barnes RK
    Med J Aust; 2010 Mar; 192(5):294-5. PubMed ID: 20306549
    [No Abstract]   [Full Text] [Related]  

  • 29. The ethics of the medical-pharmaceutical relationship.
    Vashi NA; Latkowski JA
    Clin Dermatol; 2012; 30(2):188-91. PubMed ID: 22330662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry.
    Gough IR; Dickinson I; Maddern G; Grigg M; Hillis DJ
    Med J Aust; 2010 Mar; 192(5):293-4. PubMed ID: 20201768
    [No Abstract]   [Full Text] [Related]  

  • 31. Conflicts of interest: part 1: Reconnecting the dots--reinterpreting industry-physician relations.
    Rosenbaum L
    N Engl J Med; 2015 May; 372(19):1860-4. PubMed ID: 25946288
    [No Abstract]   [Full Text] [Related]  

  • 32. No more free lunches.
    Abbasi K; Smith R
    BMJ; 2003 May; 326(7400):1155-6. PubMed ID: 12775587
    [No Abstract]   [Full Text] [Related]  

  • 33. Roche defends buying lavish meals for doctors at Sydney's restaurants.
    Moynihan R
    BMJ; 2006 Jul; 333(7560):169. PubMed ID: 16858041
    [No Abstract]   [Full Text] [Related]  

  • 34. No more free lunches: the market has us all in its grip.
    Madhavan KS
    BMJ; 2003 Aug; 327(7410):342. PubMed ID: 12907501
    [No Abstract]   [Full Text] [Related]  

  • 35. IOM warns about physician-pharma conflicts of interest.
    Landers SJ; O'Reilly KB
    Del Med J; 2009 Jul; 81(7):261-3. PubMed ID: 19902777
    [No Abstract]   [Full Text] [Related]  

  • 36. Standards of ethics at the National Institutes of Health.
    Steinbrook R
    N Engl J Med; 2005 Mar; 352(13):1290-2. PubMed ID: 15800225
    [No Abstract]   [Full Text] [Related]  

  • 37. The regulatory morass: physicians' dealings with pharmaceutical manufacturers.
    Blehart B
    J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825
    [No Abstract]   [Full Text] [Related]  

  • 38. Money for drugs: should physicians be paid for pharmaceutical development and clinical investigations?
    Van Way CW; Bohigian G
    Mo Med; 2011; 108(6):414. PubMed ID: 22338732
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmaceutical companies and medical students: a student's view.
    Hutchinson MS
    Med J Aust; 2004 Apr; 180(8):414. PubMed ID: 15089734
    [No Abstract]   [Full Text] [Related]  

  • 40. [New transparency between physicians and the pharmaceutical industry].
    Bühmann W
    Urologe A; 2014 Aug; 53(8):1170-4. PubMed ID: 25047594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.